Онкология. Журнал им. П. а герцена, 3, 2016
жүктеу/скачать 487,43 Kb. Pdf көрінісі
|
Onkologia 2016 03 080
| Rev Cancer
. 2004;4(6):448-456. doi:10.1038/nrc1370. 19. Cameron MD, Schmidt EE, Kerkvliet N et al. Temporal progression of metastasis in lung: cell survival, dormancy, and location depen- dence of metastatic inefficiency. Cancer Res. 2000;60(9):2541-2546. 20. Chambers AF, MacDonald IC, Schmidt EE, Morris VL, Groom AC. Clinical targets for anti-metastasis therapy. Adv Cancer Res. 2000;79:91-121. doi:10.1016/s0065-230x(00)79003-8. 21. Chambers AF, Naumov GN, Varghese HJ, Nadkarni KV, Mac- Donald IC, Groom AC. Critical steps in hematogenous metasta- sis: an overview. Surg Oncol Clin N Am. 2001;10(2):243-55,vii. 22. Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, ChambersA F, Groom AC. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasa- tion and limited survival of early micrometastases. Am J Pathol. 1998;153(3):865-873. 23. Chaffer CL, Weinberg RA. A perspective on cancer cell metasta- sis. Science. 2011;331(6024):1559-1564. doi:10.1126/science.1203543. 24. Wittekind C, Neid M. Cancer invasion and metastasis. Oncology. 2005;69(Suppl.1):14-16. doi:10.1159/000086626. 25. Li L, Neaves WB. Normal stem cells and cancer stem cells: the niche matters. Cancer Res. 2006;66(9):4553-4557. doi:10.1158/0008-5472.can-05-3986. 26. MacDonald IC, Groom AC, Chambers AF. Cancer spread and micrometastasis development: Quantitative approaches for in vivo models. BioEssays. 2002;24(10):885-893. doi:10.1002/bies.10156. 27. Holmgren L, O’Reilly MS, Folkman J. Dormancy of microme- tastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1(2):149-153. doi:10.1038/nm0295-149. 28. Wikman H, Vessella R, Pantel K. Cancer micrometastasis and tu- mour dormancy. APMIS. 2008;116(7-8):754-770. doi:10.1111/j.1600-0463.2008.01033.x. 29. Cristofanilli M. The «microscopic» revolution in breast carcino- ma. Cancer. 2005;103(5):877-880. doi:10.1002/cncr.20838. 30. Lugo TG, Braun S, Cote RJ et al. Detection and measurement of occult disease for the prognosis of solid tumors. J Clin Oncol. 2003;21(13):2609-2615. doi:10.1200/jco.2003.01.153. 31. Meng S, Tripathy D, Frenkel EP et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res. 2004;10(24):8152-8162. doi:10.1158/1078-0432.ccr-04-1110. 32. Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst. 1999;91(13):1113- 1124. doi:10.1093/jnci/91.13.1113. 33. Araujo RP, McElwain DLS. A history of the study of solid tumour growth: the contributionof mathematical modeling. Bull Math Biol. 2004;66(5):1039-1091. doi:10.1016/j.bulm.2003.11.002. 34. Колобов А.В., Губернов В.В., Полежаев А.А. Волны фише- ровского типа в модели роста инвазивной опухоли. Матема- тическое моделирование . 2007;19(6):31-42. 35. Swanson KR, Bridge C, Murray JD, Alvord EC Jr. Virtual and real brain tumors: using mathematical modeling to quantify glioma growth. J Neurol Sci. 2003;216(1):1-10. doi:10.1016/j.jns.2003.06.001. 36. Karrison TG, Ferguson DJ, Meier P. Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst. 1999;91(1):80-85. doi:10.1093/jnci/91.1.80. 37. Paez D, Labonte MJ, Bohanes P, Zhang W, Benhanim L, Ning Y et al. Cancer dormancy: a model of early dissemination and late cancer recurrence. Clin Cancer Res. 2012;18(3):645-653. doi:10.1158/1078-0432.ccr-11-2186. 38. Röcken M. Early tumor dissemination, but late metastasis:insights into tumor dormancy. J Clin Invest. 2010;120(6):1800-182. doi:10.1172/jci43424. 39. Karin M. Nuclear factor-kappaB in cancer development and pro- gression. Nature. 2006;441(7092):431-436. doi:10.1038/nature04870. 40. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related in- flammation. Nature. 2008;454(7203):436-444. doi:10.1038/nature07205. 41. Nickoloff BJ, Ben-Neriah Y, Pikarsky E. Inflammation and cancer: is the link as simple as we think? J Invest Dermatol. 2005;124(6):x—xiv. doi:10.1111/j.0022-202x.2005.23724.x. 42. Demicheli R, Retsky MW, Hruchetsky WJ, Baum M. Tumor dor- mancy and surgery-driven interruption of dormancy in breast can- cer: leaning from failures. Nat Clin Pract Oncol. 2007;4(12):699-710. doi:10.1038/ncponc0999. 43. Retsky M, Demicheli R, Hrushesky W, Forget P, Kock M, Gukas I et al. Reduction of breast cancer relapses with perioperative non- steroidal anti-inflammatory drugs: new findings and a review. Curr жүктеу/скачать 487,43 Kb. Достарыңызбен бөлісу:
|